Tumor-derived activated cells: culture conditions and characterization.
Maleckar
J R
JR
Biotherapeutics, Inc., Franklin, Tennessee.
Friddell
C S
CS
Lewko
W M
WM
Yannelli
J R
JR
West
W H
WH
Oldham
R K
RK
D002478:Cells, Cultured; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D008213:Lymphocyte Activation; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology
D007376:Interleukin-2; D011994:Recombinant Proteins